Cargando…

COVID-19-Related Perceived Threat Following a Second Dose Vaccination in Adults with Chronic Illness: A Mixed-Method Study

BACKGROUND: In patients with comorbidities such as chronic illness, the severity and mortality risk of the disease (COVID-19) are high. Even if they are fully vaccinated, they should follow all precautions for unvaccinated people because the vaccine may not provide them complete protection. As a res...

Descripción completa

Detalles Bibliográficos
Autores principales: Gebeyehu, Daniel Ayelegne, Sisay, Endalkachew, Molla, Bizuneh, Terefe, Bewuketu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126288/
https://www.ncbi.nlm.nih.gov/pubmed/35615583
http://dx.doi.org/10.2147/RMHP.S365389
_version_ 1784712095812550656
author Gebeyehu, Daniel Ayelegne
Sisay, Endalkachew
Molla, Bizuneh
Terefe, Bewuketu
author_facet Gebeyehu, Daniel Ayelegne
Sisay, Endalkachew
Molla, Bizuneh
Terefe, Bewuketu
author_sort Gebeyehu, Daniel Ayelegne
collection PubMed
description BACKGROUND: In patients with comorbidities such as chronic illness, the severity and mortality risk of the disease (COVID-19) are high. Even if they are fully vaccinated, they should follow all precautions for unvaccinated people because the vaccine may not provide them complete protection. As a result, understanding their response to a threat is essential because knowing their threat level can be a good predictor of behavioral changes and health-protective behaviors. METHODS: An institution-based cross-sectional mixed-method study design was used at the University of Gondar specialized hospital from May 1 to June 30, 2021. An interviewer-administered questionnaire was used for the quantitative, and tape recorders, field notes, and memos were properly taken during the in-depth interviews for the qualitative data. Multivariable logistic regression with consideration of adjusted odds ratio of 95% confidence interval and p-value of 0.05% was used for statistical significance. RESULTS: The study enrolled 239 people, with a 96% response rate, ranging from 24 to 67 years, with the majority (57.9%) male. Even after receiving the second dose of AstraZeneca, nearly half (46.5%) of participants with a chronic illness perceived a threat to COVID-19. The participant’s age ranges from 24 to 34 years [3.24 (AOR= 3.24 (95% CI: 1.08, 9.68))], patients who are student [2.38 (AOR= 2.38 (95% CI: 1.12, 5.06))], participants applying the recommended behavioral response [2.36 (AOR=2.36 (95% CI: 1.16, 4.81))] and duration of illness ranged from four to six-year [3.17 (AOR=3.17 (95% CI (1.05, 9.58))] were statistically associated with perceived threat. CONCLUSION: Most people with chronic illnesses do not see the disease as a threat. Particular emphasis should be placed on creating awareness programs and disseminating information through media on prevention, and ongoing health education is strongly advisable.
format Online
Article
Text
id pubmed-9126288
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-91262882022-05-24 COVID-19-Related Perceived Threat Following a Second Dose Vaccination in Adults with Chronic Illness: A Mixed-Method Study Gebeyehu, Daniel Ayelegne Sisay, Endalkachew Molla, Bizuneh Terefe, Bewuketu Risk Manag Healthc Policy Original Research BACKGROUND: In patients with comorbidities such as chronic illness, the severity and mortality risk of the disease (COVID-19) are high. Even if they are fully vaccinated, they should follow all precautions for unvaccinated people because the vaccine may not provide them complete protection. As a result, understanding their response to a threat is essential because knowing their threat level can be a good predictor of behavioral changes and health-protective behaviors. METHODS: An institution-based cross-sectional mixed-method study design was used at the University of Gondar specialized hospital from May 1 to June 30, 2021. An interviewer-administered questionnaire was used for the quantitative, and tape recorders, field notes, and memos were properly taken during the in-depth interviews for the qualitative data. Multivariable logistic regression with consideration of adjusted odds ratio of 95% confidence interval and p-value of 0.05% was used for statistical significance. RESULTS: The study enrolled 239 people, with a 96% response rate, ranging from 24 to 67 years, with the majority (57.9%) male. Even after receiving the second dose of AstraZeneca, nearly half (46.5%) of participants with a chronic illness perceived a threat to COVID-19. The participant’s age ranges from 24 to 34 years [3.24 (AOR= 3.24 (95% CI: 1.08, 9.68))], patients who are student [2.38 (AOR= 2.38 (95% CI: 1.12, 5.06))], participants applying the recommended behavioral response [2.36 (AOR=2.36 (95% CI: 1.16, 4.81))] and duration of illness ranged from four to six-year [3.17 (AOR=3.17 (95% CI (1.05, 9.58))] were statistically associated with perceived threat. CONCLUSION: Most people with chronic illnesses do not see the disease as a threat. Particular emphasis should be placed on creating awareness programs and disseminating information through media on prevention, and ongoing health education is strongly advisable. Dove 2022-05-19 /pmc/articles/PMC9126288/ /pubmed/35615583 http://dx.doi.org/10.2147/RMHP.S365389 Text en © 2022 Gebeyehu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Gebeyehu, Daniel Ayelegne
Sisay, Endalkachew
Molla, Bizuneh
Terefe, Bewuketu
COVID-19-Related Perceived Threat Following a Second Dose Vaccination in Adults with Chronic Illness: A Mixed-Method Study
title COVID-19-Related Perceived Threat Following a Second Dose Vaccination in Adults with Chronic Illness: A Mixed-Method Study
title_full COVID-19-Related Perceived Threat Following a Second Dose Vaccination in Adults with Chronic Illness: A Mixed-Method Study
title_fullStr COVID-19-Related Perceived Threat Following a Second Dose Vaccination in Adults with Chronic Illness: A Mixed-Method Study
title_full_unstemmed COVID-19-Related Perceived Threat Following a Second Dose Vaccination in Adults with Chronic Illness: A Mixed-Method Study
title_short COVID-19-Related Perceived Threat Following a Second Dose Vaccination in Adults with Chronic Illness: A Mixed-Method Study
title_sort covid-19-related perceived threat following a second dose vaccination in adults with chronic illness: a mixed-method study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126288/
https://www.ncbi.nlm.nih.gov/pubmed/35615583
http://dx.doi.org/10.2147/RMHP.S365389
work_keys_str_mv AT gebeyehudanielayelegne covid19relatedperceivedthreatfollowingaseconddosevaccinationinadultswithchronicillnessamixedmethodstudy
AT sisayendalkachew covid19relatedperceivedthreatfollowingaseconddosevaccinationinadultswithchronicillnessamixedmethodstudy
AT mollabizuneh covid19relatedperceivedthreatfollowingaseconddosevaccinationinadultswithchronicillnessamixedmethodstudy
AT terefebewuketu covid19relatedperceivedthreatfollowingaseconddosevaccinationinadultswithchronicillnessamixedmethodstudy